LSBio
Monoclonal Mouse anti-Human PLK1 / PLK-1 Antibody (clone OTI3F12, IHC, WB)

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PLK1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PLK1.

Monoclonal Mouse anti-Human PLK1 / PLK-1 Antibody (clone OTI3F12, IHC, WB)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Flow Cytometry, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Immunoprecipitation, Western Blot
Reactivity:Human
Format:Liquid
See all Human PLK1 / PLK-1 antibodies →
$443.00each
Catalog Number: LS-C114491-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
PLK-1 antibody LS-C114491 is an unconjugated mouse monoclonal antibody to human PLK-1 (PLK1). Validated for Flow, IHC, IP and WB. Cited in 2 publications.
Application
FC, IHC, IHC-P, IP, WB
Reactivity
Hu
Intended Use
RUO
Guarantees
This antibody carries the LSBio 100% Guarantee. ✓
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
PLK1 | Polo like kinase | Polo-like kinase (Drosophila) | Polo-like kinase 1 | STPK13 | Polo (Drosophia)-like kinase | PLK | PLK-1
Recommended Dilution: FC
1:100
Recommended Dilution: IHC-P
1:150
Recommended Dilution: WB
1:2000
UniProt Number
P53350
SwissProt
P53350

Target

Target
Human PLK1 / PLK-1
Antigen Species
Hu
Epitope
Human PLK / PLK1
Gene Name
PLK1

Antibody

Host Species
Ms
Clonality
Monoclonal
Clone
OTI3F12
Isotype
IgG1

Immunogen

Immunogen
Protein expressed in 293T cell transfected with human PLK1 expression vector.
Immunogen Type
Cell

Format

Conjugate/Label
Unconj
Format
Liquid
Formulation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Concentration
1.01 mg/mL
Volume
100 Microliter
Preservative
Yes
Purification Method
Prot A/G

Storage & Handling

Storage Conditions
Store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients. Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R. OncoTargets and therapy. 2018 March;11:1413-1422. PubMed: 29559799 PMC: PMC5857151

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.